Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature

被引:32
作者
Fu, Xinge [1 ]
Jiang, Juhong [1 ]
Tian, Xiao-ying [2 ]
Li, Zhi [3 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510120, Guangdong, Peoples R China
[2] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510080, Guangdong, Peoples R China
关键词
Epithelioid inflammatory myofibroblastic sarcoma; Inflammatory myofibroblastic tumor; Anaplastic lymphoma kinase; Differential diagnosis; Prognosis; ANAPLASTIC LYMPHOMA KINASE; LARGE-CELL LYMPHOMA; LUNG-CANCER; ALK INHIBITOR; FUSION GENE; TUMOR; CRIZOTINIB; RESISTANCE; EXPRESSION; IDENTIFICATION;
D O I
10.1186/s13000-015-0358-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is a rare variant of inflammatory myofibroblastic tumor with distinctive morphological features and malignant clinical behavior. Only a few such cases have been described in the literature. We report here a case of unusual pulmonary EIMS with multiple bone metastases. A 21-year-old Chinese male patient presented with complaints of general fatigue and rapid weight loss, and a huge tumor arising in the left lower lobe of lung was detected by chest computed tomography. The mass of lung was totally resected. Microscopically, the tumor cells were rounded and epithelioid in shape. Myxoid stroma and inflammatory infiltration was also present. The tumor cells were immunopositive to anaplastic lymphoma kinase (ALK) in smooth cytoplasmic pattern. Fluorescence in situ hybridization (FISH) assay revealed the presence of rearrangement of ALK gene. Three months after lung surgery, there were multiple bone metastases and intraspinal mass found by positron emission tomography. The second surgical treatment was performed to remove the intraspinal lesion. The histological and immunohistochemical features of intraspinal mass were similar to those of pulmonary tumor. The diagnosis of pulmonary EIMS with multiple bone metastases was made. To the best of our knowledge, it may be the first case of an EIMS arising in lung. Awareness of EIMS in respiratory tract and its distinctive features is important for pathologists to avoid a diagnostic pitfall caused by histologic similarities to other ALK-positive tumors. ALK inhibitor is a promising treatment for this aggressive tumor regardless of its potential acquired resistance.
引用
收藏
页数:8
相关论文
共 25 条
[1]   Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor [J].
Bridge, JA ;
Kanamori, M ;
Ma, ZG ;
Pickering, D ;
Hill, DA ;
Lydiatt, W ;
Lui, MY ;
Colleoni, GWB ;
Antonescu, CR ;
Ladanyi, M ;
Morris, SW .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (02) :411-415
[2]   Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor [J].
Butrynski, James E. ;
D'Adamo, David R. ;
Hornick, Jason L. ;
Dal Cin, Paola ;
Antonescu, Cristina R. ;
Jhanwar, Suresh C. ;
Ladanyi, Marc ;
Capelletti, Marzia ;
Rodig, Scott J. ;
Ramaiya, Nikhil ;
Kwak, Eunice L. ;
Clark, Jeffrey W. ;
Wilner, Keith D. ;
Christensen, James G. ;
Jaenne, Pasi A. ;
Maki, Robert G. ;
Demetri, George D. ;
Shapiro, Geoffrey I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18) :1727-1733
[3]   Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: A study of 135 cases [J].
Cessna, MH ;
Zhou, H ;
Sanger, WG ;
Perkins, SL ;
Tripp, S ;
Pickering, D ;
Daines, C ;
Coffin, CM .
MODERN PATHOLOGY, 2002, 15 (09) :931-938
[4]   An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features [J].
Chen, Sung-Ting ;
Lee, Jen-Chieh .
HUMAN PATHOLOGY, 2008, 39 (12) :1854-1858
[5]   Co-Clinical Trials Demonstrate Superiority of Crizotinib to Chemotherapy in ALK-Rearranged Non-Small Cell Lung Cancer and Predict Strategies to Overcome Resistance [J].
Chen, Zhao ;
Akbay, Esra ;
Mikse, Oliver ;
Tupper, Tanya ;
Cheng, Katherine ;
Wang, Yuchuan ;
Tan, Xiaohong ;
Altabef, Abigail ;
Woo, Sue-Ann ;
Chen, Liang ;
Reibel, Jacob B. ;
Janne, Pasi A. ;
Sharpless, Norman E. ;
Engelman, Jeffrey A. ;
Shapiro, Geoffrey I. ;
Kung, Andrew L. ;
Wong, Kwok-Kin .
CLINICAL CANCER RESEARCH, 2014, 20 (05) :1204-1211
[6]  
Coffin CM FJ, 2013, WHO CLASSIFICATION T, P83
[7]   Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor - A comparative immunohistochemical study [J].
Cook, JR ;
Dehner, LP ;
Collins, MH ;
Ma, ZG ;
Morris, SW ;
Coffin, CM ;
Hill, DA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (11) :1364-1371
[8]   Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor [J].
Cools, J ;
Wlodarska, I ;
Somers, R ;
Mentens, N ;
Pedeutour, F ;
Maes, B ;
De Wolf-Peeters, C ;
Pauwels, P ;
Hagemeijer, A ;
Marynen, P .
GENES CHROMOSOMES & CANCER, 2002, 34 (04) :354-362
[9]   Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum [J].
Debelenko, Larisa V. ;
Raimondi, Susana C. ;
Daw, Najat ;
Shivakumar, Bangalore R. ;
Huang, Dali ;
Nelson, Marilu ;
Bridge, Julia A. .
MODERN PATHOLOGY, 2011, 24 (03) :430-442
[10]   ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor [J].
Debiec-Rychter, M ;
Marynen, P ;
Hagemeijer, A ;
Pauwels, P .
GENES CHROMOSOMES & CANCER, 2003, 38 (02) :187-190